CN Patent

CN104736539A — 墨蝶呤和四氢乳酰蝶呤的制造法

Assigned to Shiratori Pharmaceutical Co Ltd · Expires 2015-06-24 · 11y expired

What this patent protects

本发明提供墨蝶呤、乳酰蝶呤以及四氢乳酰蝶呤的制造法。通过以下的反应式收率良好地获得墨蝶呤、乳酰蝶呤以及四氢乳酰蝶呤：

USPTO Abstract

本发明提供墨蝶呤、乳酰蝶呤以及四氢乳酰蝶呤的制造法。通过以下的反应式收率良好地获得墨蝶呤、乳酰蝶呤以及四氢乳酰蝶呤：

Drugs covered by this patent

Patent Metadata

Patent number
CN104736539A
Jurisdiction
CN
Classification
—
Expires
2015-06-24
Drug substance claim
No
Drug product claim
No
Assignee
Shiratori Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.